POLATUZUMAB VEDOTIN for Diffuse large b-cell lymphoma refractory: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 223 adverse event reports in the FDA FAERS database where POLATUZUMAB VEDOTIN was used for Diffuse large b-cell lymphoma refractory.
Most Reported Side Effects for POLATUZUMAB VEDOTIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 1,131 | 23.9% | 234 | 146 |
| Off label use | 692 | 14.6% | 97 | 113 |
| Anaemia | 344 | 7.3% | 48 | 127 |
| Blood lactate dehydrogenase increased | 307 | 6.5% | 66 | 49 |
| Drug ineffective | 305 | 6.4% | 72 | 52 |
| Neutropenia | 303 | 6.4% | 55 | 102 |
| Death | 295 | 6.2% | 295 | 52 |
| Covid-19 | 286 | 6.0% | 71 | 116 |
| Febrile neutropenia | 286 | 6.0% | 37 | 197 |
| Pyrexia | 285 | 6.0% | 46 | 156 |
| Thrombocytopenia | 265 | 5.6% | 56 | 103 |
| Lymphoma | 257 | 5.4% | 32 | 11 |
| Platelet count decreased | 256 | 5.4% | 47 | 77 |
| Neutrophil count decreased | 252 | 5.3% | 35 | 97 |
| Diffuse large b-cell lymphoma | 249 | 5.3% | 60 | 23 |
Other Indications for POLATUZUMAB VEDOTIN
Diffuse large b-cell lymphoma (3,196)
Product used for unknown indication (282)
B-cell lymphoma (281)
Non-hodgkin's lymphoma (169)
Follicular lymphoma (159)
Diffuse large b-cell lymphoma recurrent (98)
Diffuse large b-cell lymphoma stage iv (76)
Richter's syndrome (54)
Lymphoma (48)
Lymphoma transformation (33)
Other Drugs Used for Diffuse large b-cell lymphoma refractory
RITUXIMAB (667)
EPCORITAMAB-BYSP (353)
AXICABTAGENE CILOLEUCEL (336)
BENDAMUSTINE (283)
CYCLOPHOSPHAMIDE (226)
ETOPOSIDE (165)
POLATUZUMAB VEDOTIN-PIIQ (158)
GEMCITABINE (147)
LENALIDOMIDE (143)
DEXAMETHASONE (136)